Inventor
HYLARIDES MARK D
US14 patents
⚠️ This page may combine multiple inventors who share the name “HYLARIDES MARK D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEORX CORP
8 patentsUS5563250AOct 8, 1996
Cleavable conjugates for the delivery and release of agents in native form
NEORX CORP146 citations97
US5141648AAug 25, 1992
Methods for isolating compounds using cleavable linker bound matrices
NEORX CORP66 citations96
US6767531B2Jul 27, 2004
High dose radionuclide complexes for bone marrow suppression
NEORX CORP29 citations95
US6358710B1Mar 19, 2002
Humanized antibodies that bind to the antigen bound by antibody NR-LU-13
NEORX CORP59 citations92
US5017693AMay 21, 1991
Methods for introducing a sulfhydryl amino or hydroxyl groups to a compound
NEORX CORP27 citations92
US7097823B2Aug 29, 2006
High dose radionuclide complexes for bone marrow suppression
NEORX CORP13 citations91
US7070759B2Jul 4, 2006
High dose radionuclide complexes for bone marrow suppression
NEORX CORP9 citations72
US5911969AJun 15, 1999
Pretargeting protocols for enhanced localization of active agents to target sites
NEORX CORP10 citations72
PONIARD PHARMACEUTICALS INC
3 patentsUS7696331B2Apr 13, 2010
High dose radionuclide complexes for bone marrow treatment
PONIARD PHARMACEUTICALS INC7 citations72
US7408046B2Aug 5, 2008
Treatment of bone-associated cancers
PONIARD PHARMACEUTICALS INC6 citations72
US7378077B2May 27, 2008
High dose radionuclide complexes for bone marrow suppression
PONIARD PHARMACEUTICALS INC6 citations72